About Nova Biomedical

Nova Biomedical Headquarters
Waltham, Massachusetts

Nova Biosensor Technical Firsts

  • 1978: First biosensor for Ionized Calcium
  • 1980: First biosensor to measure Chloride in blood
  • 1984: First biosensor to measure Total Calcium
  • 1985: First biosensor to measure Hematocrit by ISE/Conductivity
  • 1987: First biosensor to directly measure whole blood Glucose
  • 1988: First biosensor to measure Lithium
  • 1990: First biosensor to measure BUN (urea)
  • 1992: First biosensor to directly measure whole blood Lactate
  • 1994: First biosensor to measure Ionized Magnesium
  • 1996: First biosensor to measure Creatinine
  • 1996: First biosensor to measure Total CO2 in whole blood
  • 1997: First muti-wavelength fiber optic SO2% assay
  • 1998: First fiber optic Hemoglobin assay
  • 1998: First Ammonium biosensor
  • 1999: First non-diluting direct Glutamine biosensor
  • 2001: First Acetate biosensor
  • 2005: First Hematocrit corrected Glucose test strip
  • 2007: First Calibration-free Glucose test strip
  • 2008: First Creatinine test strip
  • 2009: First Hematocrit corrected Ketone test strip
  • 2010: First Hematocrit corrected Lactate test strip for hospital use

Hospital Based Blood Testing Analyzers

Nova Biomedical is the world technology leader in the development of fast whole blood analyzers to support the care of critically ill patients. Compared to any competitive alternative, Nova analyzers have the most extensive stat test menus and deliver these tests in the shortest time at the lowest costs. In addition Nova provides point of care, hand held meter and strip based systems for glucose, ketone, lactate and creatinine testing. Whether testing is performed in the central laboratory, emergency department, surgery, critical care, or respiratory care, Nova can help improve patient outcomes while reducing the cost of care.

NOVA employs over 800 people worldwide, has sales and service subsidiaries in 6 countries and distributors in over 80 other countries.

Chemistry Analyzers for Biotechnology

Nova manufactures a series of BioProfile® automated chemistry and cell analysis analyzers for rapid testing of key nutrients, metabolites, gases and cell status in cell culture and fermentation media.

Self-Testing Diabetes Products

Nova develops and manufactures blood glucose test strips and monitors for self testing by diabetics. These glucose monitors are distributed under the NovaMax® label in the US and Canada and under the Menarini label in Europe.

Product Development and Manufacturing for Corporate Partners

In addition to Nova brand products, our Contract Services Division develops and manufactures medical devices and diagnostic products for many of the world's leading healthcare corporations. Nova's Contract Services Division has established itself as one of the leading medical product development and manufacturing companies in the world by designing only to the highest standards of quality and reliability, and manufacturing at the lowest costs.

Pioneering Technological Innovations

Nova Biomedical has a 32-year history of being the world's leader in developing biosensors for whole blood and cell culture/fermentation diagnostics.